KRS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $522K | Sell |
1,287
-12
| -0.9% | -$4.87K | 0.35% | 65 |
|
|
2025
Q1 | $646K | Sell |
1,299
-18
| -1% | -$8.96K | 0.51% | 45 |
|
|
2024
Q4 | $685K | Buy |
1,317
+20
| +2% | +$10.4K | 0.48% | 46 |
|
|
2024
Q3 | $802K | Sell |
1,297
-83
| -6% | -$51.3K | 0.58% | 35 |
|
|
2024
Q2 | $763K | Sell |
1,380
-50
| -3% | -$27.6K | 0.57% | 35 |
|
|
2024
Q1 | $831K | Buy |
1,430
+83
| +6% | +$48.2K | 0.67% | 31 |
|
|
2023
Q4 | $715K | Sell |
1,347
-50
| -4% | -$26.5K | 0.67% | 41 |
|
|
2023
Q3 | $707K | Hold |
1,397
| – | – | 0.75% | 35 |
|
|
2023
Q2 | $729K | Buy |
1,397
+56
| +4% | +$29.2K | 0.73% | 33 |
|
|
2023
Q1 | $773K | Buy |
1,341
+5
| +0.4% | +$2.88K | 0.87% | 29 |
|
|
2022
Q4 | $736K | Buy |
1,336
+10
| +0.8% | +$5.51K | 1.01% | 27 |
|
|
2022
Q3 | $672K | Hold |
1,326
| – | – | 0.93% | 28 |
|
|
2022
Q2 | $720K | Hold |
1,326
| – | – | 1.03% | 26 |
|
|
2022
Q1 | $783K | Hold |
1,326
| – | – | 0.85% | 30 |
|
|
2021
Q4 | $884K | Buy |
+1,326
| New | +$884K | 0.76% | 27 |
|